We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Anna MacDonald

Anna MacDonald profile page

Senior Science Editor

 at Technology Networks


After obtaining a first-class honors degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.


Education


University of East Anglia  


Areas of Expertise



Got a Question for Anna MacDonald?


Get in touch using the contact form linked here and we'll get back to you shortly.



Published Content
Total: 341
The gloved hands of a scientist holding badges displaying various LGBTQIA+ pride flags.
Listicle

Creating Space in Science: LGBTQIA+ Voices on Belonging in Pharma

In this listicle, LGBTQIA+ scientists offer insights into how inclusion can be built into everyday lab culture, from normalizing pronoun sharing and celebrating diverse holidays to rethinking policy and representation.
Digital illustration of a glowing circular DNA strand representing minicircle DNA structure.
Industry Insight

Unlocking the Potential of Minicircle DNA

In this interview, we explore the limitations of pDNA, the advantages of mcDNA and how NunaBio’s technology could unlock new possibilities for safer, more efficient gene therapy.
Colorful monoclonal antibodies on a red background.
Industry Insight

Advancing QC for Complex Biologics

David Curtin discusses how the integration of MALS detectors with Empower software enhances biopharmaceutical QC, aligns with evolving regulatory demands and supports the future of complex biologic product analysis.
3D illustration of a purple mRNA strand on a purple and blue background.
Industry Insight

How Is AI Shaping the Future of mRNA Therapeutics?

Learn more about how AI is advancing the mRNA drug discovery pipeline and what we can expect to see in the future in this interview with Dr. Davide De Lucrezia.
Newborn baby lying on a blanket being examined by a healthcare professional.
Industry Insight

Shaping the Future of Newborn Screening

Dr. Madhuri Hegde discusses Revvity's role in the Generation Study, an ambitious initiative that will sequence the genomes of 100,000 newborns.
Hand holding a small wooden cube with a green tick, symbolizing verification, surrounded by vegetation.
Industry Insight

Funding Will Advance Third-Party Verified Sustainability in Science

James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.
Representation of the ubiquitin-proteosome pathway.
Industry Insight

Unlocking the Potential of PROTACs in Drug Discovery

To explore how PROTACs are transforming drug discovery, we spoke with Robyn Stoller, business development manager at Cytiva.
Cartoon female and male scientist surrounded by a DNA helix, vaccine vial and drug capsule.
Industry Insight

How Is the Cell and Gene Therapy Landscape Evolving?

To explore how the CGT landscape is evolving, Technology Networks spoke with Betty Woo, vice president of Cell, Gene and Advanced Therapies at Thermo Fisher Scientific.
Three hands holding wooden jigsaw pieces together.
Industry Insight

Driving Customer-Centric Innovation: Agilent’s Organizational Transformation

In this Q&A, Padraig McDonnell discusses how the reorganization aligns with Agilent’s commitment to innovation and customer success, the expected benefits of the new structure and the steps being taken to ensure a seamless transition.
Oversized red magnifying glass placed among a group of human figures.
Industry Insight

Unlocking the Human Proteome

We spoke with Dr. Michael Gonzales to learn more about the UKB-PPP and its goals, the technical hurdles of large-scale proteomics and how Olink technology is helping to overcome them.
Advertisement